Trial intelligence / Profile preview

Pharmacokinetics of prednisolone in children with airway disease (POP child)

2017-003590-33Phase 4Terminated

Sponsor
Bispebjerg and Frederiksberg Hospital
Start
Sep 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of prednisolone in asthma, asthmatic bronchitis and airway diseases (4 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Saliva prednisolone pharmacokinetics. Started Sep 2017; status: terminated.

02

Drugs

prednisolone
03

Conditions

asthmaasthmatic bronchitisairway diseases

Beyond the preview

Go deeper on 2017-003590-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-003590-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call